Pinsent Masons advises Bell on the sale of the ZIMBO plants to Zur-Mühlen Group

05 Jul 2019 | 02:59 pm | 1 min. read

Bell Food Group is divesting its German sausage products business and will in future focus in Germany on its strong position in the air-dried ham segment.

A team led by Dr Thomas Peschke advised Swiss Bell Food Group on the sale of its German sausage products business to Zur-Mühlen Group. Zur-Mühlen Group takes over the German sausage products division of Bell Food Group and the sites in Suhl and Börger, including approximately 400 employees. By this takeover, Zur-Mühlen Group is focusing even stronger on the sausage products business and will continue to expand its position on the German market, whereas Bell Food Group will in Germany focus on expanding its position in the segment of top-quality German and international air-dried ham.

The transaction is subject to the approval of the competent competition authorities.

Bell Food Group is one of the leading meat and convenience processors in Europe. Its range includes meat, poultry, cold cuts, fish and seafood as well as convenience products. With the Bell, Eisberg, Hilcona and Hügli brands, the group meets the diverse needs of its customers in the retail, food service and food industry sectors. Around 12,500 employees generate annual sales of over CHF 4 billion. Bell Food Group is listed on the Swiss stock exchange.

This was the first time that Dr Thomas Peschke's team has worked for the Bell Group since joining Pinsent Masons. Dr. Thomas Peschke is an experienced M&A lawyer with a focus on the food and beverage sector.

Meet the team

Show me all
Dr. Thomas Peschke

Rechtsanwalt, Partner

Thomas specialises in advising national and international clients on M&A transactions, on the formation of joint ventures and on corporate reorganisations.

Peschke Thomas
Dr. Thomas Wölfl LL.M.

Rechtsanwalt, Legal Director

Thomas is a Real estate and environmental specialist with long-standing experience advising investors, developers and businesses in a range of sectors including Energy and Infrastructure.

Woelfl Thomas
Dr. Heyo Maas

Rechtsanwalt, Senior Associate

Heyo has more than 13 years experience in domestic and international M&A transactions and corporate reorganisations.

Maas Heyo
Dr. Nils Rauer, MJI

Rechtsanwalt, Partner

Nils leads the TMT team in our Frankfurt office with a focus on digitisation projects, the protection, use and enforcement of data and intangible rights, notably copyright and trade secrets.

Rauer Nils
Dr. Michael Reich

Rechtsanwalt, Partner, Head of Competition, Germany

Michael advises on all aspects of German and European competition law.

Reich Michael
Julia Haas

Rechtsanwältin

Julia Haas is a lawyer specialising in competition law.

Julia Haas
Werner Geißelmeier

Rechtsanwalt, Partner

Werner specialises in Tax law.

Geisselmeier Werner

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or